{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:44:22Z","timestamp":1773873862969,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["109437"],"award-info":[{"award-number":["109437"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R007942\/1"],"award-info":[{"award-number":["MR\/R007942\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00381-021-05163-2","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T15:20:11Z","timestamp":1618500011000},"page":"2625-2634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Risk factors for ischemic stroke in children with tuberculous meningitis"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5607-8443","authenticated-orcid":false,"given":"Regan S.","family":"Solomons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarel T.","family":"Nieuwoudt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Seddon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"van Toorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"5163_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1128\/CMR.00042-07","volume":"21","author":"RB Rock","year":"2008","unstructured":"Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK (2008) Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 21:243\u2013261 table of contents","journal-title":"Clin Microbiol Rev"},{"key":"5163_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12889-018-5252-9","volume":"18","author":"K du Preez","year":"2018","unstructured":"du Preez K, Schaaf HS, Dunbar R, Walters E, Swartz A, Solomons R, Hesseling AC (2018) Complementary surveillance strategies are needed to better characterise the epidemiology, care pathways and treatment outcomes of tuberculosis in children. BMC Public Health 18:397","journal-title":"BMC Public Health"},{"key":"5163_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.spen.2014.01.006","volume":"21","author":"R van Toorn","year":"2014","unstructured":"van Toorn R, Solomons R (2014) Update on the diagnosis and management of tuberculous meningitis in children. Semin Pediatr Neurol 21:12\u201318","journal-title":"Semin Pediatr Neurol"},{"key":"5163_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S1473-3099(14)70852-7","volume":"14","author":"SS Chiang","year":"2014","unstructured":"Chiang SS, Khan FA, Milstein MB, Tolman AW, Benedetti A, Starke JR, Becerra MC (2014) Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 14:947\u2013957","journal-title":"Lancet Infect Dis"},{"key":"5163_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/STROKEAHA.109.567735","volume":"41","author":"JJ Sheu","year":"2010","unstructured":"Sheu JJ, Chiou HY, Kang JH, Chen YH, Lin HC (2010) Tuberculosis and the risk of ischemic stroke: a 3-year follow-up study. Stroke 41:244\u2013249","journal-title":"Stroke"},{"key":"5163_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ejpn.2008.07.004","volume":"13","author":"P Springer","year":"2009","unstructured":"Springer P, Swanevelder S, van Toorn R, van Rensburg AJ, Schoeman J (2009) Cerebral infarction and neurodevelopmental outcome in childhood tuberculous meningitis. Eur J Paediatr Neurol 13:343\u2013349","journal-title":"Eur J Paediatr Neurol"},{"key":"5163_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jns.2010.12.015","volume":"303","author":"UK Misra","year":"2011","unstructured":"Misra UK, Kalita J, Maurya PK (2011) Stroke in tuberculous meningitis. J Neurol Sci 303:22\u201330","journal-title":"J Neurol Sci"},{"key":"5163_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jinf.2009.07.012","volume":"59","author":"GA Lammie","year":"2009","unstructured":"Lammie GA, Hewlett RH, Schoeman JF, Donald PR (2009) Tuberculous cerebrovascular disease: a review. J Infect 59:156\u2013166","journal-title":"J Infect"},{"key":"5163_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1177\/088307389501000417","volume":"10","author":"JF Schoeman","year":"1995","unstructured":"Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR (1995) Serial CT scanning in childhood tuberculous meningitis: prognostic features in 198 cases. J Child Neurol 10:320\u2013329","journal-title":"J Child Neurol"},{"key":"5163_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/01.STR.19.2.200","volume":"19","author":"R Leiguarda","year":"1988","unstructured":"Leiguarda R, Berthier M, Starkstein S, Nogues M, Lylyk P (1988) Ischemic infarction in 25 children with tuberculous meningitis. Stroke 19:200\u2013204","journal-title":"Stroke"},{"key":"5163_CR11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jocn.2006.07.014","volume":"14","author":"SB Koh","year":"2007","unstructured":"Koh SB, Kim BJ, Park MH, Yu SW, Park KW, Lee DH (2007) Clinical and laboratory characteristics of cerebral infarction in tuberculous meningitis: a comparative study. J Clin Neurosci 14:1073\u20131077","journal-title":"J Clin Neurosci"},{"key":"5163_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1473-3099(10)70138-9","volume":"10","author":"S Marais","year":"2010","unstructured":"Marais S, Thwaites G, Schoeman JF, Torok ME, Misra UK, Prasad K, Donald PR, Wilkinson RJ, Marais BJ (2010) Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis 10:803\u2013812","journal-title":"Lancet Infect Dis"},{"key":"5163_CR13","first-page":"582","volume":"251","author":"Streptomycin in Tuberculosis Trials Committee MRC","year":"1948","unstructured":"Streptomycin in Tuberculosis Trials Committee MRC (1948) Streptomycin treatment of tuberculous meningitis. Lancet 251:582\u2013596","journal-title":"Lancet"},{"key":"5163_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.5588\/ijtld.11.0648","volume":"16","author":"R van Toorn","year":"2012","unstructured":"van Toorn R, Springer P, Laubscher JA, Schoeman JF (2012) Value of different staging systems for predicting neurological outcome in childhood tuberculous meningitis. Int J Tuberc Lung Dis 16:628\u2013632","journal-title":"Int J Tuberc Lung Dis"},{"key":"5163_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/INF.0000000000000065","volume":"33","author":"R van Toorn","year":"2014","unstructured":"van Toorn R, Schaaf HS, Laubscher JA, van Elsland SL, Donald PR, Schoeman JF (2014) Short intensified treatment in children with drug-susceptible tuberculous meningitis. Pediatr Infect Dis J 33:248\u2013252","journal-title":"Pediatr Infect Dis J"},{"key":"5163_CR16","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00381-008-0785-3","volume":"25","author":"M Pienaar","year":"2009","unstructured":"Pienaar M, Andronikou S, van Toorn R (2009) MRI to demonstrate diagnostic features and complications of TBM not seen with CT. Childs Nerv Syst 25:941\u2013947","journal-title":"Childs Nerv Syst"},{"key":"5163_CR17","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1161\/STROKEAHA.118.021301","volume":"49","author":"M Wasay","year":"2018","unstructured":"Wasay M, Khan M, Farooq S, Khowaja ZA, Bawa ZA, Mansoor Ali S, Awan S, Beg MA (2018) Frequency and impact of cerebral infarctions in patients with tuberculous meningitis. Stroke 49:2288\u20132293","journal-title":"Stroke"},{"key":"5163_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/qjmed\/hcq103","volume":"103","author":"HK Anuradha","year":"2010","unstructured":"Anuradha HK, Garg RK, Agarwal A, Sinha MK, Verma R, Singh MK, Shukla R (2010) Predictors of stroke in patients of tuberculous meningitis and its effect on the outcome. QJM 103:671\u2013678","journal-title":"QJM"},{"key":"5163_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.2008-1353","volume":"123","author":"GT van Well","year":"2009","unstructured":"van Well GT, Paes BF, Terwee CB, Springer P, Roord JJ, Donald PR, van Furth AM, Schoeman JF (2009) Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics 123:e1\u2013e8","journal-title":"Pediatrics"},{"key":"5163_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000292023","volume":"17","author":"RS Kashyap","year":"2010","unstructured":"Kashyap RS, Deshpande PS, Ramteke SR, Panchbhai MS, Purohit HJ, Taori GM, Daginawala HF (2010) Changes in cerebrospinal fluid cytokine expression in tuberculous meningitis patients with treatment. Neuroimmunomodulation 17:333\u2013339","journal-title":"Neuroimmunomodulation"},{"key":"5163_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/cid\/ciu781","volume":"60","author":"DH Visser","year":"2015","unstructured":"Visser DH, Solomons RS, Ronacher K, van Well GT, Heymans MW, Walzl G, Chegou NN, Schoeman JF, van Furth AM (2015) Host immune response to tuberculous meningitis. Clin Infect Dis 60:177\u2013187","journal-title":"Clin Infect Dis"},{"key":"5163_CR22","doi-asserted-by":"publisher","first-page":"28220","DOI":"10.1074\/jbc.271.45.28220","volume":"271","author":"M Ryuto","year":"1996","unstructured":"Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K, Kuwano M (1996) Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271:28220\u201328228","journal-title":"J Biol Chem"},{"key":"5163_CR23","first-page":"CD002244","volume":"4","author":"K Prasad","year":"2016","unstructured":"Prasad K, Singh MB, Ryan H (2016) Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 4:CD002244","journal-title":"Cochrane Database Syst Rev"},{"key":"5163_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jns.2010.03.025","volume":"293","author":"UK Misra","year":"2010","unstructured":"Misra UK, Kalita J, Nair PP (2010) Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. J Neurol Sci 293:12\u201317","journal-title":"J Neurol Sci"},{"key":"5163_CR25","doi-asserted-by":"crossref","unstructured":"Mai NT, Dobbs N, Phu NH, Colas RA, Thao LT, Thuong NT, Nghia HD, Hanh NH, Hang NT, Heemskerk AD, Day JN, Ly L, Thu DD, Merson L, Kestelyn E, Wolbers M, Geskus R, Summers D, Chau NV, Dalli J, Thwaites GE (2018) A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults. Elife 7:e33478","DOI":"10.7554\/eLife.33478"},{"key":"5163_CR26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/0883073811398132","volume":"26","author":"JF Schoeman","year":"2011","unstructured":"Schoeman JF, Janse van Rensburg A, Laubscher JA, Springer P (2011) The role of aspirin in childhood tuberculous meningitis. J Child Neurol 26:956\u2013962","journal-title":"J Child Neurol"},{"key":"5163_CR27","doi-asserted-by":"publisher","unstructured":"SURE: Short intensive treatment for children with tuberculous meningitis. ISRCTN registry identifier 40829906. Retrieved from https:\/\/doi.org\/10.1186\/ISRCTN40829906","DOI":"10.1186\/ISRCTN40829906"},{"key":"5163_CR28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","volume":"163","author":"LG Corral","year":"1999","unstructured":"Corral LG, Haslett PA, Muller GW, Chen R, Wong LM, Ocampo CJ, Patterson RT, Stirling DI, Kaplan G (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol 163:380\u2013386","journal-title":"J Immunol"},{"key":"5163_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/08830738060210040801","volume":"21","author":"JF Schoeman","year":"2006","unstructured":"Schoeman JF, Fieggen G, Seller N, Mendelson M, Hartzenberg B (2006) Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases. J Child Neurol 21:301\u2013308","journal-title":"J Child Neurol"},{"key":"5163_CR30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/INF.0000000000000539","volume":"34","author":"R van Toorn","year":"2015","unstructured":"van Toorn R, du Plessis AM, Schaaf HS, Buys H, Hewlett RH, Schoeman JF (2015) Clinicoradiologic response of neurologic tuberculous mass lesions in children treated with thalidomide. Pediatr Infect Dis J 34:214\u2013218","journal-title":"Pediatr Infect Dis J"},{"key":"5163_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1086\/315721","volume":"182","author":"A Gori","year":"2000","unstructured":"Gori A, Rossi MC, Trabattoni D, Marchetti G, Fusi ML, Molteni C, Clerici M, Franzetti F (2000) Tumor necrosis factor-alpha increased production during thalidomide treatment in patients with tuberculosis and human immunodeficiency virus coinfection. J Infect Dis 182:639\u2013640","journal-title":"J Infect Dis"},{"key":"5163_CR32","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1086\/315328","volume":"181","author":"LG Bekker","year":"2000","unstructured":"Bekker LG, Haslett P, Maartens G, Steyn L, Kaplan G (2000) Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis. J Infect Dis 181:954\u2013965","journal-title":"J Infect Dis"},{"key":"5163_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5694\/mja14.00716","volume":"202","author":"JS Molton","year":"2015","unstructured":"Molton JS, Huggan PJ, Archuleta S (2015) Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction. Med J Aust 202:156\u2013157","journal-title":"Med J Aust"},{"key":"5163_CR34","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1097\/INF.0000000000002578","volume":"39","author":"YN Abo","year":"2020","unstructured":"Abo YN, Curtis N, Butters C, Rozen TH, Marais BJ, Gwee A (2020) Successful treatment of a severe vision-threatening paradoxical tuberculous reaction with infliximab: first pediatric use. Pediatr Infect Dis J 39:e42\u2013e45","journal-title":"Pediatr Infect Dis J"},{"key":"5163_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","volume":"13","author":"R Ruslami","year":"2013","unstructured":"Ruslami R, Ganiem AR, Dian S, Apriani L, Achmad TH, van der Ven AJ, Borm G, Aarnoutse RE, van Crevel R (2013) Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis 13:27\u201335","journal-title":"Lancet Infect Dis"},{"key":"5163_CR36","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/cpt.202","volume":"98","author":"RM Savic","year":"2015","unstructured":"Savic RM, Ruslami R, Hibma JE, Hesseling A, Ramachandran G, Ganiem AR, Swaminathan S, McIlleron H, Gupta A, Thakur K, van Crevel R, Aarnoutse R, Dooley KE (2015) Pediatric tuberculous meningitis: model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children. Clin Pharmacol Ther 98:622\u2013629","journal-title":"Clin Pharmacol Ther"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-021-05163-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-021-05163-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-021-05163-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T04:45:30Z","timestamp":1698900330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-021-05163-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["5163"],"URL":"https:\/\/doi.org\/10.1007\/s00381-021-05163-2","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Health Research Ethics Committee of Stellenbosch University (study nr. U17\/10\/047).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}